Stay updated on Dose Ranging Study of PF-06700841 Cream in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Dose Ranging Study of PF-06700841 Cream in Atopic Dermatitis Clinical Trial page.

Latest updates to the Dose Ranging Study of PF-06700841 Cream in Atopic Dermatitis Clinical Trial page
- CheckyesterdayChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed from the page's revision history.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check37 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2 on the page footer.SummaryDifference0.0%

- Check44 days agoChange DetectedMinor metadata update: the page revision changed from v3.4.0 to v3.4.1; no impact on study content or user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check66 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed.SummaryDifference0.0%

- Check95 days agoChange DetectedNew study sites were added across multiple US states and internationally (New South Wales, Victoria, Manitoba, Ontario, Quebec, Hokkaido, Osaka, Tokyo) with revision to v3.3.3. The prior location list (v3.3.2) and the HHS Vulnerability Disclosure entry were removed.SummaryDifference2%

Stay in the know with updates to Dose Ranging Study of PF-06700841 Cream in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dose Ranging Study of PF-06700841 Cream in Atopic Dermatitis Clinical Trial page.